Synthaverse S.A. (FRA:6NQ)

Germany · Delayed Price · Currency is EUR

0.7050

-0.0060 (-0.84%)

At close: Aug 26, 2026

-38.48% (1Y)

Market Cap	53.33M -34.3%
Revenue (ttm)	9.82M -40.8%
Net Income	-5.35M
EPS	-0.07
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.7060
Previous Close	0.7110
Day's Range	0.7050 - 0.7100
52-Week Range	0.5930 - 1.1480
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 30, 2026

About Synthaverse

Synthaverse S.A., a pharmaceutical company, manufactures and sells medicinal preparations, medical devices, and laboratory reagents for use in oncology, gynecology, hematology, immunology, and related therapeutic areas in Poland, the rest of the European Union, and internationally. The company operates through the BCG and Traditional segments. The company offers OnkoBCG 50 and 100, which are oncological immunotherapy products used to treat superficial and non-invasive bladder tumors; GAMMA anti-D 50 and GAMMA anti-D 150, which are human anti-rh... [Read more]

Industry Biological Products, Except Diagnostic Substances

Founded 1944

Employees 214

Stock Exchange Frankfurt Stock Exchange

Ticker Symbol 6NQ

Financial Performance

Financial numbers in PLN Financial Statements